Patents by Inventor Barbara A. Chapman
Barbara A. Chapman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20090210359Abstract: The invention relates an apparatus (20) for merchandising including a point of sale (29), a stock of at least one product for sale (36, 38, 40), and a display point (22, 24, 26) having at least one package (30, 32, 34), the package including a replica of the at least one product for sale, wherein the apparatus is arranged to enable the package to be exchanged for the at least one product.Type: ApplicationFiled: March 22, 2007Publication date: August 20, 2009Applicant: Chapman Research LimitedInventor: Barbara Chapman
-
Patent number: 7139805Abstract: A system for providing Java-implemented Application Servers to a plurality of clients. Each of the Java-implemented Application Servers is configured to execute on a processing element of a server which has multiple independent processing elements arranged such that a failure of one processing element does not affect the operability of the other processing elements. A Distributor is provided to enable making connections with the clients and then determine which of the Application Servers actually services the clients requests. The Distributor attempts to choose the Application Server that has the fewest number of clients as the server for a new client request. A monitoring program restarts the Distributor if it fails. The system thus provides a scalable and available set of Java-implemented Application Servers without requiring any change to the Java-implemented application itself.Type: GrantFiled: May 30, 2001Date of Patent: November 21, 2006Assignee: Hewlett-Packard Development Company, L.P.Inventors: Charles F. Seagren, Barbara A. Chapman
-
Publication number: 20060122376Abstract: Recombinant protein complexes having human Factor VIII:C activity are expressed in a eukaryotic host cell by transforming the host cell with first and second expression cassettes encoding a first polypeptide substantially homologous to human Factor VIII:C A domain and a second polypeptide substantially homologous to human Factor VIII:C C domain, respectively. In the present invention, the first polypeptide may be extended having at its C-terminal a human Factor VIII:C B domain N-terminal peptide, a polypeptide spacer of 3-40 amino acids, and a human Factor VIII:C B domain C-terminal peptide. Expression of the second polypeptide is improved by employing an .alpha.sub.1-antitrypsin signal sequence.Type: ApplicationFiled: November 30, 2005Publication date: June 8, 2006Applicant: Chiron CorporationInventors: Barbara Chapman, Rae Burke, Mirella Rasmussen, Jan Mikkelson
-
Publication number: 20040137579Abstract: Recombinant protein complexes having human Factor VIII:C activity are expressed in a eukaryotic host cell by transforming the host cell with first and second expression cassettes encoding a first polypeptide substantially homologous to human Factor VIII:C A domain and a second polypeptide substantially homologous to human Factor VIII:C C domain, respectively. In the present invention, the first polypeptide may be extended having at its C-terminal a human Factor VIII:C B domain N-terminal peptide, a polypeptide spacer of 3-40 amino acids, and a human Factor VIII:C B domain C-terminal peptide. Expression of the second polypeptide is improved by employing an &agr;1-antitrypsin signal sequence.Type: ApplicationFiled: December 1, 2003Publication date: July 15, 2004Applicants: Chiron Corporation, Novo Nordisk A/SInventors: Barbara Chapman, Rae Lyn Burke, Mirella Ezban Rasmussen, Jan Mollar Mikkelson
-
Publication number: 20030170825Abstract: Recombinant protein complexes having human Factor VIII:C activity are expressed in a eukaryotic host cell by transforming the host cell with first and second expression cassettes encoding a first polypeptide substantially homologous to human Factor VIII:C A domain and a second polypeptide substantially homologous to human Factor VIII:C C domain, respectively. In the present invention, the first polypeptide may be extended having at its C-terminal a human Factor VIII:C B domain N-terminal peptide, a polypeptide spacer of 3-40 amino acids, and a human Factor VIII:C B domain C-terminal peptide. Expression of the second polypeptide is improved by employing an &agr;1-antitrypsin signal sequence.Type: ApplicationFiled: September 26, 2002Publication date: September 11, 2003Applicant: Chiron CorporationInventors: Barbara Chapman, Rae Lyn Burke, Mirella Ezban Rasmussen, Jan Moller Mikkelson
-
Publication number: 20020007410Abstract: A system for providing Java-implemented Application Servers to a plurality of clients. Each of the Java-implemented Application Servers is configured to execute on a processing element of a server which has multiple independent processing elements arranged such that a failure of one processing element does not affect the operability of the other processing elements. A Distributor is provided to enable making connections with the clients and then determine which of the Application Servers actually services the clients requests. The Distributor attempts to choose the Application Server that has the fewest number of clients as the server for a new client request. A monitoring program restarts the Distributor if it fails. The system thus provides a scalable and available set of Java-implemented Application Servers without requiring any change to the Java-implemented application itself.Type: ApplicationFiled: May 30, 2001Publication date: January 17, 2002Inventors: Charles F. Seagren, Barbara A. Chapman
-
Publication number: 20010016340Abstract: Recombinant protein complexes having human Factor VIII:C activity are expressed in a eukaryotic host cell by transforming the host cell with first and second expression cassettes encoding a first polypeptide substantially homologous to human Factor VIII:C A domain and a second polypeptide substantially homologous to human Factor VIII:C C domain, respectively. In the present invention, the first polypeptide may be extended having at its C-terminal a human Factor VIII:C B domain N-terminal peptide, a polypeptide spacer of 3-40 amino acids, and a human Factor VIII:C B domain C-terminal peptide. Expression of the second polypeptide is improved by employing an &agr;1-antitrypsin signal sequence.Type: ApplicationFiled: December 22, 2000Publication date: August 23, 2001Applicant: Chiron Corporation and Novo Nordisk A/SInventors: Barbara Chapman, Rae Lyn Burke, Mirella Ezban Rasmussen, Jan Moller Mikkelson
-
Patent number: 6228620Abstract: Recombinant protein complexes having human Factor VIII:C activity are expressed in a eukaryotic host cell by transforming the host cell with first and second expression cassettes encoding a first polypeptide substantially homologous to human Factor VIII:C A domain and a second polypeptide substantially homologous to human Factor VIII:C C domain, respectively. In the present invention, the first polypeptide may be extended having at its C-terminal a human Factor VIII:C B domain N-terminal peptide, a polypeptide spacer of 3-40 amino acids, and a human Factor VIII:C B domain C-terminal peptide. Expression of the second polypeptide is improved by employing an &agr;1-antitrypsin signal sequence.Type: GrantFiled: May 16, 1995Date of Patent: May 8, 2001Assignees: Chiron Corporation, Novo Nordisk A/SInventors: Barbara Chapman, Rae Lyn Burke, Mirella Ezban Rasmussen, Jan Moller Mikkelson
-
Patent number: 6060447Abstract: Recombinant protein complexes having human Factor VIII:C activity are expressed in a eukaryotic host cell by transforming the host cell with first and second expression cassettes encoding a first polypeptide substantially homologous to human Factor VIII:C A domain and a second polypeptide substantially homologous to human Factor VIII:C C domain, respectively. In the present invention, the first polypeptide may be extended having at its C-terminal a human Factor VIII:C B domain N-terminal peptide, a polypeptide spacer of 3-40 amino acids, and a human Factor VIII:C B domain C-terminal peptide. Expression of the second polypeptide is improved by employing an .alpha..sub.1 -antitrypsin signal sequence.Type: GrantFiled: May 16, 1995Date of Patent: May 9, 2000Assignees: Chiron Corporation, Novo Nordisk A/SInventors: Barbara Chapman, Rae Lyn Burke, Mirella Ezban Rasmussen, Jan Moller Mikkelson
-
Patent number: 5789203Abstract: Recombinant protein complexes having human Factor VIII:C activity are expressed in a eukaryotic host cell by transforming the host cell with first and second expression cassettes encoding a first polypeptide substantially homologous to human Factor VIII:C A domain and a second polypeptide substantially homologous to human Factor VIII:C C domain, respectively. In the present invention, the first polypeptide may be extended having at its C-terminal a human Factor VIII:C B domain N-terminal peptide, a polypeptide spacer of 3-40 amino acids, and a human Factor VIII:C B domain C-terminal peptide. Expression of the second polypeptide is improved by employing an .alpha..sub.1 -antitrypsin signal sequence.Type: GrantFiled: June 27, 1994Date of Patent: August 4, 1998Assignees: Chiron Corporation, Novo Nordisk A/SInventors: Barbara Chapman, Rae Lyn Burke, Mirella Ezban Rasmussen, Jan Moller Mikkelson
-
Patent number: 5595886Abstract: DNA constructs encoding human Factor VIII:C protein are disclosed. In particular, the DNA construct contains a nucleotide sequence that encodes a first polypeptide homologous to the A domain of human Factor VIII:C linked to a second polypeptide homologous to the C domain of human Factor VIII:C by a polypeptide spacer that comprises a peptide homologous to a human Ig heavy chain hinge region. Recombinant methods for producing human Factor VIII:C protein are also disclosed.Type: GrantFiled: December 3, 1993Date of Patent: January 21, 1997Assignee: Chiron CorporationInventors: Barbara Chapman, Rae L. Burke